Tensha Therapeutics VP of Sales Salaries in Boulder | Comparably
Tensha Therapeutics develops small molecule bromodomain inhibitors to treat cancer and other serious disorders. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
102

Tensha Therapeutics VP of Sales Salaries in Boulder

The average Tensha Therapeutics VP of Sales in Boulder earns an estimated $296,744 annually, which includes an estimated base salary of $188,348 with a $108,395 bonus. Tensha Therapeutics' VP of Sales compensation is $2,339,453 less than the US average for a VP of Sales. VP of Sales salaries at Tensha Therapeutics in Boulder can range from $125,467 - $700,000.

In Boulder, The Sales Department at Tensha Therapeutics earns $15,525 more on average than the Finance Department.

Last updated 5 years ago.

$60k
$122k
$212k
$300k
$3.56B
$296,744
Average Compensation
$188,348
avg. base
$108,395
avg. bonus

VP of Sales Salaries at Tensha Therapeutics

In Boulder, VPs of Sales earn $75,443 more than Directors of Sales.

Director of Sales
$221k*
Sales Manager
$164k*
Sales Engineer
$142k*
Sales Rep
$120k*
Sales Associate
$65k*
* estimated salary

Compensation at Tensha Therapeutics by Department

In Boulder, The Sales Department averages $15,525 more than the Finance Department, and $5,360 less than the IT Department

IT
$96,997 Avg. total comp.
+$5k
Sales
$91,637 Avg. total comp.
Finance
$76,112 Avg. total comp.
-$16k

VP of Sales Compensation by Gender (All Companies)

The average female VP of Sales at companies similar size to Tensha Therapeutics reported making $326,625, while the average male VP of Sales at similar sized companies reported making $314,005.

VP of Sales Compensation by Ethnicity (All Companies)

The average Hispanic or Latino VP of Sales at companies similar size to Tensha Therapeutics reported making $371,333, while the average Asian or Pacific Islander VP of Sales at similar sized companies reported making $260,050.

How VPs of Sales at Tensha Therapeutics Rate Their Compensation

100% say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Tensha Therapeutics

×
Rate your company